NCT03528265View on ClinicalTrials.gov

Adapting LFI for Melioidosis

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 21, 2018

Primary Completion Date

January 8, 2019

Study Completion Date

January 8, 2019

Conditions
Melioidosis
Interventions
DEVICE

Lateral flow immunoassay

Biospecimens of patients with melioidosis-like symptoms will be tested with lateral flow immunoassay to detect Burkholderia pseudomallei, bacterium causing melioidosis

Trial Locations (1)

Unknown

Kapit Hospital, Kapit

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER